azd6793
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 15, 2024 (NCT06368440)
Timeline
Indications
Mechanism of action
IRAK4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07082738 | Phase 2 | Jun 27, 2025 | AstraZeneca |
| NCT06494644 | Phase 1 | Jul 23, 2024 | AstraZeneca |
| NCT06368440 | Phase 1 | May 15, 2024 | AstraZeneca |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1